Canagliflozin/dapagliflozinFournier gangrene following off label use: 3 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1823卷 / 1期

关键词：

D O I：

10.1007/s40278-020-83730-8

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：102 / 102

相关论文

共 50 条

[1] SpironolactoneHyperkalaemia following off label use: 3 case reports
Reactions Weekly, 2019, 1765 (1) : 296 - 296
[2] SevofluraneVarious toxicities following off label use: 3 case reports
Reactions Weekly, 2019, 1758 (1) : 319 - 319
[3] IvabradineVarious toxicities following off label use: 3 case reports
Reactions Weekly, 2020, 1833 (1) : 226 - 226
[4] ParacetamolHaemolysis following off-label use: 3 case reports
Reactions Weekly, 2022, 1917 (1) : 472 - 472
[5] LenvatinibVarious toxicities following off label use: 3 case reports
Reactions Weekly, 2017, 1668 (1) : 247 - 247
[6] RituximabVarious toxicities following off label use: 3 case reports
Reactions Weekly, 2021, 1856 (1) : 357 - 357
[7] SpironolactoneHyperkalaemia following off-label use: 3 case reports
Reactions Weekly, 2023, 1949 (1) : 385 - 385
[8] NabiloneSedation and xerostomia following off label use: 3 case reports
Reactions Weekly, 2017, 1667 (1) : 245 - 245
[9] ImiquimodLymphoedema following off-label use: 3 case reports
Reactions Weekly, 2018, 1711 (1) : 146 - 146
[10] HydroxychloroquineHypoglycaemia following off-label use: 3 case reports
Reactions Weekly, 2020, 1822 (1) : 152 - 152

← 1 2 3 4 5 →